BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Everson GT. Increasing incidence and pretransplantation screening of hepatocellular carcinoma. Liver Transpl 2000;6:s2-s10. [DOI: 10.1053/jlts.2000.1918] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 1.4] [Reference Citation Analysis]
Number Citing Articles
1 Wolf D. Screening for hepatocellular carcinoma: Is it cost-effective? Liver Transplantation 2003;9:682-3. [DOI: 10.1053/jlts.2003.50139] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
2 Masuzaki R, Yoshida H, Kato N, Omata M. Hepatitis C and Hepatocellular Carcinoma. In: Carr BI, editor. Hepatocellular Carcinoma. Totowa: Humana Press; 2010. pp. 259-81. [DOI: 10.1007/978-1-60327-376-3_8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
3 Cho CS, Gonen M, Shia J, Kattan MW, Klimstra DS, Jarnagin WR, D’Angelica MI, Blumgart LH, DeMatteo RP. A novel prognostic nomogram is more accurate than conventional staging systems for predicting survival after resection of hepatocellular carcinoma. J Am Coll Surg. 2008;206:281-291. [PMID: 18222381 DOI: 10.1016/j.jamcollsurg.2007.07.031] [Cited by in Crossref: 83] [Cited by in F6Publishing: 83] [Article Influence: 5.5] [Reference Citation Analysis]
4 Arguedas MR, Chen VK, Eloubeidi MA, Fallon MB. Screening for hepatocellular carcinoma in patients with hepatitis C cirrhosis: a cost-utility analysis. Am J Gastroenterol. 2003;98:679-690. [PMID: 12650806 DOI: 10.1111/j.1572-0241.2003.07327.x] [Cited by in Crossref: 188] [Cited by in F6Publishing: 153] [Article Influence: 9.9] [Reference Citation Analysis]
5 Nguyen MH, Keeffe EB. Screening for hepatocellular carcinoma. J Clin Gastroenterol. 2002;35:S86-S91. [PMID: 12394211 DOI: 10.1097/00004836-200211002-00004] [Cited by in Crossref: 61] [Cited by in F6Publishing: 58] [Article Influence: 3.2] [Reference Citation Analysis]
6 Masuzaki R, Omata M. HCC Screening and Surveillance. In: Al Knawy B, Reddy K, Bolondi L, editors. Hepatocellular Carcinoma. CRC Press; 2009. pp. 26-35. [DOI: 10.3109/9780203092880-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
7 Daniele B, Bencivenga A, Megna AS, Tinessa V. Alpha-fetoprotein and ultrasonography screening for hepatocellular carcinoma. Gastroenterology. 2004;127:S108-S112. [PMID: 15508073 DOI: 10.1053/j.gastro.2004.09.023] [Cited by in Crossref: 233] [Cited by in F6Publishing: 209] [Article Influence: 12.9] [Reference Citation Analysis]
8 Leung JY, Zhu AX, Gordon FD, Pratt DS, Mithoefer A, Garrigan K, Terella A, Hertl M, Cosimi AB, Chung RT. Liver transplantation outcomes for early-stage hepatocellular carcinoma: results of a multicenter study. Liver Transpl. 2004;10:1343-1354. [PMID: 15497158 DOI: 10.1002/lt.20311] [Cited by in Crossref: 104] [Cited by in F6Publishing: 88] [Article Influence: 6.1] [Reference Citation Analysis]
9 Carlis L, Giacomoni A, Lauterio A, Slim A, Sammartino C, Pirotta V, Colella G, Forti D. Liver transplantation for hepatocellular cancer: should the current indication criteria be changed? Transplant Int 2003;16:115-22. [DOI: 10.1111/j.1432-2277.2003.tb00272.x] [Cited by in Crossref: 43] [Cited by in F6Publishing: 34] [Article Influence: 2.3] [Reference Citation Analysis]
10 Ringe B. Transplantation for liver tumors: current status: Transplantation for liver tumors. Liver 2002;22:1-7. [DOI: 10.1034/j.1600-0676.2002.220101.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
11 Li D, Mallory T, Satomura S. AFP-L3: a new generation of tumor marker for hepatocellular carcinoma. Clin Chim Acta. 2001;313:15-19. [PMID: 11694234 DOI: 10.1016/s0009-8981(01)00644-1] [Cited by in Crossref: 200] [Cited by in F6Publishing: 91] [Article Influence: 10.0] [Reference Citation Analysis]
12 Sakpal SV, Agarwal SK, Saucedo-Crespo H, Auvenshine C, Santella RN, Donahue S, Steers J. Transplant Critical Care: Is there a Need for Sub-specialized Units? - A Perspective. J Crit Care Med (Targu Mures) 2018;4:83-9. [PMID: 30582000 DOI: 10.2478/jccm-2018-0014] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
13 Brown DB, Fundakowski CE, Lisker-Melman M, Crippin JS, Pilgram TK, Chapman W, Darcy MD. Comparison of MELD and Child-Pugh scores to predict survival after chemoembolization for hepatocellular carcinoma. J Vasc Interv Radiol. 2004;15:1209-1218. [PMID: 15525739 DOI: 10.1097/01.rvi.0000128123.04554.c1] [Cited by in Crossref: 63] [Cited by in F6Publishing: 15] [Article Influence: 3.7] [Reference Citation Analysis]
14 Hiatt JR, Carmody IC, Busuttil RW. Should we expand the criteria for hepatocellular carcinoma with living-donor liver transplantation?--no, never. J Hepatol 2005;43:573-7. [PMID: 16112768 DOI: 10.1016/j.jhep.2005.07.017] [Cited by in Crossref: 37] [Cited by in F6Publishing: 30] [Article Influence: 2.2] [Reference Citation Analysis]
15 Marsh JW, Finkelstein SD, Demetris AJ, Swalsky PA, Sasatomi E, Bandos A, Subotin M, Dvorchik I. Genotyping of hepatocellular carcinoma in liver transplant recipients adds predictive power for determining recurrence-free survival. Liver Transpl. 2003;9:664-671. [PMID: 12827550 DOI: 10.1053/jlts.2003.50144] [Cited by in Crossref: 104] [Cited by in F6Publishing: 89] [Article Influence: 5.5] [Reference Citation Analysis]
16 Hayashi PH, Di Bisceglie AM. The progression of hepatitis B- and C-infections to chronic liver disease and hepatocellular carcinoma: presentation, diagnosis, screening, prevention, and treatment of hepatocellular carcinoma. Infect Dis Clin North Am 2006;20:1-25. [PMID: 16527646 DOI: 10.1016/j.idc.2006.01.003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
17 Ahn J, Flamm SL. Hepatocellular carcinoma. Dis Mon 2004;50:556-73. [PMID: 15616490 DOI: 10.1016/j.disamonth.2004.10.001] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 1.3] [Reference Citation Analysis]
18 Marsh JW, Dvorchik I. Liver organ allocation for hepatocellular carcinoma: are we sure? Liver Transpl. 2003;9:693-696. [PMID: 12827554 DOI: 10.1053/jlts.2003.50086] [Cited by in Crossref: 97] [Cited by in F6Publishing: 88] [Article Influence: 5.1] [Reference Citation Analysis]
19 Kurtovic J, Riordan SM, Williams R. Liver transplantation for hepatocellular carcinoma. Best Pract Res Clin Gastroenterol. 2005;19:147-160. [PMID: 15757810 DOI: 10.1016/j.bpg.2004.10.002] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 0.9] [Reference Citation Analysis]
20 Freedman BJ, Lowe SC, Saouaf R. MR IMAGING IN HEPATIC TRANSPLANTATION. Magnetic Resonance Imaging Clinics of North America 2001;9:821-39. [DOI: 10.1016/s1064-9689(21)00276-2] [Cited by in Crossref: 5] [Article Influence: 0.2] [Reference Citation Analysis]
21 Bolondi L. Screening for hepatocellular carcinoma in cirrhosis. Journal of Hepatology 2003;39:1076-84. [DOI: 10.1016/s0168-8278(03)00349-0] [Cited by in Crossref: 135] [Cited by in F6Publishing: 49] [Article Influence: 7.1] [Reference Citation Analysis]
22 Maciel AC, Cerski CT, Moreira RK, Resende VL, Zanotelli ML, Matiotti SB. Hepatocellular carcinoma in patients undergoing orthotopic liver transplantation: radiological findings with anatomopathological correlation in Brazil. Arq Gastroenterol 2006;43:24-9. [DOI: 10.1590/s0004-28032006000100008] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
23 De Carlis L, Giacomoni A, Pirotta V, Lauterio A, Slim AO, Sammartino C, Cardillo M, Forti D. Surgical treatment of hepatocellular cancer in the era of hepatic transplantation. Journal of the American College of Surgeons 2003;196:887-97. [DOI: 10.1016/s1072-7515(03)00140-6] [Cited by in Crossref: 60] [Cited by in F6Publishing: 16] [Article Influence: 3.2] [Reference Citation Analysis]
24 Mendiratta-lala M, Park H, Kolicaj N, Mendiratta V, Bassi D. Small intrahepatic peripheral cholangiocarcinomas as mimics of hepatocellular carcinoma in multiphasic CT. Abdom Radiol 2017;42:171-8. [DOI: 10.1007/s00261-016-0840-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
25 Arguedas MR. Screening for hepatocellular carcinoma: Why, when, how? Curr Gastroenterol Rep 2003;5:57-62. [DOI: 10.1007/s11894-003-0010-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
26 Donckier V, Van Laethem JL, Van Gansbeke D, Ickx B, Lingier P, Closset J, El Nakadi I, Feron P, Boon N, Bourgeois N, Adler M, Gelin M. New considerations for an overall approach to treat hepatocellular carcinoma in cirrhotic patients. J Surg Oncol 2003;84:36-44. [DOI: 10.1002/jso.10281] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.6] [Reference Citation Analysis]
27 Hayashi PH, Di Bisceglie AM. The progression of hepatitis B– and C–infections to chronic liver disease and hepatocellular carcinoma: presentation, diagnosis, screening, prevention, and treatment of hepatocellular carcinoma. Medical Clinics of North America 2005;89:345-69. [DOI: 10.1016/j.mcna.2004.08.007] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
28 Li J, Wang J, Zhou W, Zhang S, Le Y, He R. Downregulation of BRAF-activated non-coding RNA suppresses the proliferation, migration and invasion, and induces apoptosis of hepatocellular carcinoma cells. Oncol Lett 2017;14:4751-7. [PMID: 29085476 DOI: 10.3892/ol.2017.6770] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
29 Mok TS, Choi E, Yau D, Johri A, Yeo W, Chan AT, Wong C. Effects of patupilone (epothilone B; EPO906), a novel chemotherapeutic agent, in hepatocellular carcinoma: an in vitro study. Oncology 2006;71:292-6. [PMID: 17657173 DOI: 10.1159/000106450] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]